CDMO for EMBED 3.0 Research Study
Estimated value
—
Awarded value
£325k
Suppliers
1
Lots
1
Published
27 Apr 2026
Description
Due to the highly specific technical requirements regarding product manufacture (microinjection-moulding (MIM) of formulations containing API) it rapidly became clear that we needed to separate the production from the clinical trial services and identify separate vendors for these services. At the current stage of the program, the identification and selection of a Contract Development and Manufacturing Organization (CDMO) was prioritized by the EMBED team and the funder.
Scope
- Reference
- ocds-h6vhtk-068b66
- Commercial tool
- Standalone contract
Submission & procedure
- Procedure
- Direct award
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£325k
Award date
—
Contract start
14 May 2026
Contract end
31 Dec 2026
Awarded suppliers· 1 supplier
Awarded — · Contract period 14 May 2026 — 31 Dec 2026
Other contracts from Cardiff University
Full notice and award history for this contracting authority is on the buyer profile.
Other contracts awarded to ProMed Pharma, LLC· 1
Cross-buyer view of this supplier's public-sector wins.
| Title | Type | Value | Published |
|---|---|---|---|
| CDMO for EMBED 3.0 Research Study | contract | — | 27 Apr 2026 |